the Consumer Price Index (CPI) rose 488 percent. In contrast, an index of physician fees adjusted for 1) overall inflation, and 2) the declining proportion which is paid out-of-pocket by the patient, declined over the same 30-year period. This last observation, pointing to the erosion of the market, is important for structuring price competition for physician services. For insured patients, out-of-pocket payments arise from deductibles, coinsurance and limits, each of which is briefly discussed in this article. Following a review of Medicare Part B physician reimbursement, the paper shows that limits can be used to strengthen the incentive which insured patients have to search for less expensive medical care
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Economics, 2016."June 2016." Ca...
About one-third of Americans age 65 and older supplement their Medicare health insurance through a p...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...
SUMMARY Understanding competition in the US drug market requires knowing how sensitive demand is to ...
Chapter 1 investigates whether physicians' financial incentives influence health care supply, techn...
Rising pharmaceutical expenditures have led to the use of cost-sharing measures. The authors underto...
This paper studies a market for a medical product in which there is perfect competition among health...
This paper estimates the price sensitivity of medical care demand from cross-sectional survey data b...
43 p.Recent publicity about “concierge physicians” has raised concerns about the potential adverse e...
This dissertation consists of two essays in economics of industrial organization on private Medicare...
Non-transparent information about prices is a key piece of many economic models. George Stigler's se...
BACKGROUND: Patient copayments for all medical services have increased dramatically. There are few d...
H ealth care expenditures have grown from 4.4 percent of the U.S. econ-omy in 1950 to over 13 percen...
One commonly held explanation for high and rising health care costs in the United States points to t...
Thesis (Ph. D.)--University of Rochester. Department of Economics, 2018.In chapter one, I study how ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Economics, 2016."June 2016." Ca...
About one-third of Americans age 65 and older supplement their Medicare health insurance through a p...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...
SUMMARY Understanding competition in the US drug market requires knowing how sensitive demand is to ...
Chapter 1 investigates whether physicians' financial incentives influence health care supply, techn...
Rising pharmaceutical expenditures have led to the use of cost-sharing measures. The authors underto...
This paper studies a market for a medical product in which there is perfect competition among health...
This paper estimates the price sensitivity of medical care demand from cross-sectional survey data b...
43 p.Recent publicity about “concierge physicians” has raised concerns about the potential adverse e...
This dissertation consists of two essays in economics of industrial organization on private Medicare...
Non-transparent information about prices is a key piece of many economic models. George Stigler's se...
BACKGROUND: Patient copayments for all medical services have increased dramatically. There are few d...
H ealth care expenditures have grown from 4.4 percent of the U.S. econ-omy in 1950 to over 13 percen...
One commonly held explanation for high and rising health care costs in the United States points to t...
Thesis (Ph. D.)--University of Rochester. Department of Economics, 2018.In chapter one, I study how ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Economics, 2016."June 2016." Ca...
About one-third of Americans age 65 and older supplement their Medicare health insurance through a p...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...